Sort
46,585 grants matching “heart failure”
Cardioprotective mechanisms of novel noncoding RNA in myocardial infarction
$640,287Eduardo Marban · Cedars-Sinai Medical Center · R01 · FY2024 · HL
Aging Fitness & Failure: Mechanisms of Diastolic Dysfunction
$640,227Benjamin D Levine · Ut Southwestern Medical Center · R01 · FY2014 · AG
Multi-Ethnic Study of Atherosclerosis-Eye Study
$640,138University Of Wisconsin Madison · R01 · FY2002 · HL
Cardiac Magnetic Resonance for Tissue Characterization Based Risk Stratification of Cardiopulmonary Symptoms, Effort Tolerance, and Prognosis Among COVID-19 Survivors
$640,107Jiwon Kim · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · HL
Development of a Fully-Implantable Ventricular Assist Device for Neonates and Children with Heart Failure - with Magnetic Levitation to Improve Hemocompatibility
$640,106O. H. Frazier · Texas Heart Institute · R01 · FY2021 · HL
My-BP-C Modulation of Cardiac Contraction
$640,025Richard L Moss · University Of Wisconsin-Madison · R37 · FY2015 · HL
Circulating Dietary & Metabolic Fatty Acids, Major CVD Outcomes, & Healthy Aging
$640,001Dariush Mozaffarian · Tufts University Boston · R01 · FY2015 · HL
Mechanisms of Clinical and Hemodynamic Response to Pulmonary Vasodilator Therapy in Fontan physiology
$639,980Alexander Egbe · Mayo Clinic Rochester · R01 · FY2023 · HL
An Intervention to Improve ICD Deactivation Conversations
$639,973Nathan E Goldstein · Icahn School Of Medicine At Mount Sinai · R01 · FY2015 · HL
Right Ventricular-Pulmonary Vascular Interactions in Pulmonary Hypertension
$639,932Naomi C Chesler · University Of Wisconsin-Madison · R01 · FY2011 · HL
Seeking Objectivity in Allocation of Advanced Heart Failure (SOCIAL HF) Therapies Trial
$639,893Khadijah Breathett · Indiana University Indianapolis · R01 · FY2023 · HL
Risk Stratification in MADIT II Type Patients
$639,881Wojciech Zareba · University Of Rochester · R01 · FY2007 · HL
Cardiovascular Consequences of Duchenne and Becker Muscular Dystrophinopathies
$639,855Melissa A.h. Witman · University Of Delaware · R01 · FY2022 · HL
Nrf2 regulation of oxidative stress in heart failure and extra vesicular communication
$639,851Irving H Zucker · University Of Nebraska Medical Center · R01 · FY2021 · HL
Neutral sphingomyelinase in the mechanical regulation of the heart
$639,822Alexey V Glukhov · University Of Wisconsin-Madison · R01 · FY2025 · HL
The Cause of Systemic Inflammatory Response during Cardiopulmonary Bypass and Prevention by Nitric Oxide
$639,812Alvaro Rojas-Pena · University Of Michigan At Ann Arbor · R01 · FY2021 · HL
Transvenous Optoacoustic-Ultrasound Guided Cold Laser Wire for Crossing Coronary Chronic Total Occlusion
$639,770Thomas E. Milner · University Of California-Irvine · R01 · FY2023 · HL
Development of a Porcine Model of Severe Tricuspid Regurgitation
$639,763Kurt W Prins · University Of Minnesota · R01 · FY2024 · HL
Left ventricular physiological effects of veno-arterial ECMO support during cardiogenic shock
$639,761Demetris Yannopoulos · University Of Minnesota · R01 · FY2024 · HL
Probing the Cardiac PGC-1 Regulatory Cascade
$639,721Daniel Patrick Kelly · University Of Pennsylvania · R01 · FY2024 · HL
Inflammation and platelet activation
$639,627Craig Fletcher · Johns Hopkins University · P60 · FY2010 · MD
Circulating Dietary & Metabolic Fatty Acids, Major CVD Outcomes, & Healthy Aging
$639,617Dariush Mozaffarian · Tufts University Boston · R01 · FY2016 · HL
Heart Failure in the Community
$639,592Veronique L Roger · Mayo Clinic Rochester · R01 · FY2006 · HL
MHC and KIR Sequencing and Association Analyses in the iGeneTRAiN Studies
$639,512Brendan James Keating · New York University School Of Medicine · U01 · FY2024 · AI
Live-Cell Fluorescence Lifetime FRET Assays for HTS
$639,512Gregory David Gillispie · Fluorescence Innovations, Inc. · R42 · FY2016 · DA